Rosenblatt’s senior analyst John McPeake believes the recent pullback in Nebius (NBIS) stock has created a buying opportunity for long-term investors. McPeake initiated NBIS this week with a “Buy” rating and a bullish $304 price objective, indicating potential upside of nearly 65% from current levels.
Despite recent weakness, Nebius shares remain a lucrative investment for 2026, currently trading at more than 2x their price at the start of this year.
